Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3584903efe1babebbd056e855a2cc2b3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
filingDate |
2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f22b481241fa3c76f1c5708fcadce4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4781d7b2926f4d0bf3de35ad507c3275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67fe71796bf11d374f8e6540e0a956da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c4aa6536c61f8cfd28c526cc4721ff8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0fa5ca984165faf6f7c9dec57330d0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d46b339b93bfabb114a5941a0ed82097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5853fdeaf8deccdfb90bf3ca4c802c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc100d8cb4b5bdc67a4347316d6b4071 |
publicationDate |
2022-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022274935-A1 |
titleOfInvention |
Pharmaceutical composition for preventing or treating bone diseases |
abstract |
A composition according to an embodiment of the present disclosure includes a compound represented by Formula 1. The composition may inhibit osteoclast differentiation and/or formation and exhibit excellent prophylactic or therapeutic effects on various bone diseases including periodontitis and the like. A method for treating a bone disease caused by hyperdifferentiation of osteoclasts according to an embodiment of the present disclosure includes administering to a subject in need thereof the composition. |
priorityDate |
2019-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |